Tumor vasculature (liver tumor blood supply)

The phrase "Tumor vasculature via hepatic artery embolization with local beta-radiation delivery from yttrium‑90" does not refer to a single molecular target or receptor. Instead, it describes a **therapeutic approach** for treating liver tumors—specifically hepatocellular carcinoma or metastatic disease—by targeting the **tumor’s vascular supply** through the hepatic artery. In this procedure: • The hepatic artery is catheterized and blocked using particles or beads (“embolization”), which cuts off the highly oxygenated blood that sustains most liver tumors[1][2]. • In radioembolization (“selective internal radiation therapy” or SIRT), these beads are loaded with radioactive yttrium‑90. Once lodged in the small vessels feeding the tumor, they deliver localized beta radiation directly to cancer cells while sparing most healthy tissue[2][3]. • This method exploits the fact that normal liver tissue receives most of its blood from the portal vein while tumors rely on arterial flow[1]. This is not a molecular target such as a receptor or enzyme but rather an anatomical/physiological feature exploited for therapy. The actual “target” is **the network of arteries supplying blood to malignant lesions in the liver**, not a specific molecule. Because this entry refers to an interventional radiology technique rather than a discrete biological molecule/receptor/protein/gene: • It should be flagged as incorrect if used as a canonical drug target. • There is no standard abbreviation. • No direct biomarkers exist for patient selection beyond imaging evidence of hypervascularity. • Safety concerns include post-procedure pain/fever (“postembolization syndrome”), risk of non-target embolization/injury, and potential for acute liver failure especially in those with underlying cirrhosis[4][6]. In summary: This term describes an interventional treatment strategy—not a canonical molecular drug target—and should be corrected if entered into structured databases as such.

Other names

Hepatic artery tumor blood supplyLiver tumor vasculatureTumor vascular bed (liver)Hepatic arterial supply to tumors

Local delivery of beta-radiation via yttrium‑90 microspheres causes DNA damage and cell death in nearby tumor cells [2][3] Embolization blocks arterial blood flow, depriving the tumor of oxygen and nutrients [1][2][5]